Please use this identifier to cite or link to this item: https://hdl.handle.net/10356/47456
Full metadata record
DC FieldValueLanguage
dc.contributor.authorBahareh Haji Rasoulihaen
dc.date.accessioned2011-12-27T08:22:00Zen
dc.date.available2011-12-27T08:22:00Zen
dc.date.copyright2010en
dc.date.issued2010en
dc.identifier.citationBahareh, H. R. (2010). LC-MS/MS proteomics analysis of biomarkers in Singapore breast cancer patients on doxorubicin treatment and MCF7 breast cancer derived cells. Master’s thesis, Nanyang Technological University, Singapore.en
dc.identifier.urihttps://hdl.handle.net/10356/47456en
dc.description97 p.en
dc.description.abstractBreast cancer is known as the most common cancer in women population, especially in developed countries. Improved prognosis and effective treatment are needed to reduce the mortality of the disease. Doxorubicin, a topoisomerase II-targeting chemotherapeutic drug has been widely used to treat breast cancer. The rapidly evolved proteomics techniques, especially LC-MS/MS analysis, has been used in protein profiling in body fluids as well as cells, which provide us with a deep comprehension in drugs mechanism and patients response to the treatment. This new method can be extended in biomarker identification to improve diagnosis and monitoring of treatment.en
dc.rightsNanyang Technological Universityen
dc.subjectDRNTU::Engineering::Chemical engineering::Biotechnologyen
dc.titleLC-MS/MS proteomics analysis of biomarkers in Singapore breast cancer patients on doxorubicin treatment and MCF7 breast cancer derived cellsen
dc.typeThesisen
dc.contributor.supervisorChen Wei Ning, Williamen
dc.contributor.schoolSchool of Chemical and Biomedical Engineeringen
dc.description.degreeMASTER OF ENGINEERING (SCBE)en
dc.identifier.doi10.32657/10356/47456en
item.fulltextWith Fulltext-
item.grantfulltextopen-
Appears in Collections:SCBE Theses
Files in This Item:
File Description SizeFormat 
SCBE_THESES_1.pdf9.83 MBAdobe PDFThumbnail
View/Open

Google ScholarTM

Check

Altmetric

Items in DR-NTU are protected by copyright, with all rights reserved, unless otherwise indicated.